Investment
Features
FeesSafety
Academy
More
Pluang+

Humana shares jump 16% on improved Medicare Advantage Star Ratings; CVS falls 3%, UnitedHealth steady.

Market News
09 Oct 2026
24/7 Wall Street
View Source
Bullish
Humana shares jump 16% on improved Medicare Advantage Star Ratings; CVS falls 3%, UnitedHealth steady.

Humana's stock surged 16% after the company announced improved Medicare Advantage Star Ratings for 2027, with 95% of its members enrolled in plans rated four stars or higher. This improvement reflects better preventive care and earlier disease detection efforts by Humana, boosting its competitive edge during the annual enrollment period. Meanwhile, CVS Health shares dropped 3%, and UnitedHealth remained steady, highlighting differing impacts of the ratings on diversified insurers. Investors will watch if Humana can sustain these ratings gains and if CVS and UnitedHealth recover as the ratings news settles.

Humana shares jumped 16.54% to USD 451.15 on Pluang as of Oct 09, 2026 19:51 WIB, reflecting strong investor response to its improved Medicare Advantage Star Ratings. CVS Health saw a 2.41% decline to USD 85.68, while UnitedHealth edged up 1.06% to USD 374.90, showing mixed reactions among health insurers on the platform. Typical hold times vary, with Humana at 53 days, CVS at 83 days, and UnitedHealth at 97 days, indicating differing investor confidence levels.

More News (HUM)

Humana shares jump as Medicare Advantage contract earns 4-star rating for 2027, boosting profit outlook.

Humana shares jump as Medicare Advantage contract earns 4-star rating for 2027, boosting profit outlook.

Humana's stock surged after its main Medicare Advantage plan regained a 4-star rating for 2027 from the Centers for Medicare and Medicaid Services, up from 3.5 stars in 2026. This upgrade means 95% of Humana's Medicare Advantage members will be in pl...

Analyst Insights
Bullish
12 hours ago
Oppenheimer raises Humana price target to $475 on strong Medicare Advantage ratings.

Oppenheimer raises Humana price target to $475 on strong Medicare Advantage ratings.

Oppenheimer upgraded Humana's price target from $405 to $475, citing strong performance in Medicare Advantage plans where 95% of members are in four-star or higher rated plans. This upgrade implies a potential 22.7% upside from Humana's current stock...

Analyst Insights
Bullish
17 hours ago
Medicare Advantage plans with 4+ stars drop 18%, but enrollment in top plans rises, signaling rating changes, not care quality.

Medicare Advantage plans with 4+ stars drop 18%, but enrollment in top plans rises, signaling rating changes, not care quality.

The Centers for Medicare & Medicaid Services (CMS) announced an 18% drop in Medicare Advantage contracts rated four stars or higher for 2027, due to changes in rating criteria including new medication-safety measures and increased weight on physical ...

Market News
Neutral
19 hours ago
Humana shares jump 15% as 95% of Medicare Advantage members qualify for 4-star plans in 2027

Humana shares jump 15% as 95% of Medicare Advantage members qualify for 4-star plans in 2027

Humana's shares rose nearly 15% after the company improved its Medicare Advantage quality ratings for 2027, with about 95% of members enrolled in plans rated at least four stars. The company now has 18 contracts rated four stars or higher, including ...

Market News
Bullish
20 hours ago
Medicare Advantage plans are shutting down, risking coverage changes for nearly 1M members.

Medicare Advantage plans are shutting down, risking coverage changes for nearly 1M members.

Nearly 1 million Medicare Advantage members face plan shutdowns from providers like UnitedHealth and Humana, risking loss of current coverage. While this reduces insurer costs and improves margins, affected members must act by December 7 to secure Me...

Market News
Neutral
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App